AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$595M |
| 2 |
Verisk Analytics
VRSK
|
+$499M |
| 3 |
Otis Worldwide
OTIS
|
+$484M |
| 4 |
lululemon athletica
LULU
|
+$408M |
| 5 |
Microsoft
MSFT
|
+$346M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$384M |
| 2 |
Nike
NKE
|
+$341M |
| 3 |
Arista Networks
ANET
|
+$335M |
| 4 |
Visa
V
|
+$331M |
| 5 |
Cognizant
CTSH
|
+$308M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.66% |
| 2 | Healthcare | 18% |
| 3 | Financials | 11.03% |
| 4 | Consumer Discretionary | 10.25% |
| 5 | Industrials | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2976
ALX Oncology
ALXO
$272M
| $193K | ﹤0.01% |
40,290
+1,710
| +4% | +$9.28K |
|
2977
PDS Biotechnology
PDSB
$38.7M
| $191K | ﹤0.01% |
37,840
| – | – |
|
2978
Tejon Ranch
TRC
$476M
| $191K | ﹤0.01% |
11,772
-20
| -0.2% | -$338 |
|
|
HLVX
2979
DELISTED
HilleVax
HLVX
| $190K | ﹤0.01% |
14,110
+1,960
| +16% | +$27.6K |
|
2980
Waterstone Financial
WSBF
$363M
| $187K | ﹤0.01% |
17,120
| – | – |
|
2981
Arbutus Biopharma
ABUS
$871M
| $185K | ﹤0.01% |
91,100
+6,930
| +8% | +$14.5K |
|
|
SILV
2982
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $182K | ﹤0.01% |
41,232
+23,580
| +134% | +$120K |
|
2983
TeraWulf
WULF
$8.91B
| $181K | ﹤0.01% |
143,570
+111,870
| +353% | +$265K |
|
2984
Future Fuel
FF
$203M
| $180K | ﹤0.01% |
25,150
+10,223
| +68% | +$83.7K |
|
|
BIG
2985
DELISTED
Big Lots, Inc.
BIG
| $179K | ﹤0.01% |
35,100
| – | – |
|
2986
RE/MAX Holdings
RMAX
$207M
| $179K | ﹤0.01% |
13,830
-89,973
| -87% | -$1.56M |
|
|
BRT
2987
BRT Apartments
BRT
$283M
| $178K | ﹤0.01% |
10,280
+240
| +2% | +$4.54K |
|
2988
Clarus
CLAR
$126M
| $174K | ﹤0.01% |
23,034
| – | – |
|
|
CRON
2989
Cronos Group
CRON
$1.07B
| $173K | ﹤0.01% |
86,596
+59,578
| +221% | +$116K |
|
2990
Voyager Therapeutics
VYGR
$187M
| $170K | ﹤0.01% |
21,930
+2,690
| +14% | +$24.6K |
|
2991
Janux Therapeutics
JANX
$950M
| $170K | ﹤0.01% |
16,860
+1,830
| +12% | +$21.1K |
|
2992
GCM Grosvenor
GCMG
$756M
| $170K | ﹤0.01% |
21,880
+2,630
| +14% | +$20.4K |
|
|
JBIO
2993
Jade Biosciences
JBIO
$1.21B
| $169K | ﹤0.01% |
356
+21
| +6% | +$11.4K |
|
2994
IAMGOLD
IAG
$8.5B
| $167K | ﹤0.01% |
77,500
| – | – |
|
|
PSTL
2995
Postal Realty Trust
PSTL
$722M
| $166K | ﹤0.01% |
12,330
+170
| +1% | +$2.46K |
|
|
NSTG
2996
DELISTED
NanoString Technologies, Inc.
NSTG
| $166K | ﹤0.01% |
96,660
-500
| -0.5% | -$1.52K |
|
|
MRSN
2997
DELISTED
Mersana Therapeutics
MRSN
| $166K | ﹤0.01% |
5,230
-3,439
| -40% | -$163K |
|
2998
Rayonier Advanced Materials
RYAM
$573M
| $166K | ﹤0.01% |
46,850
+9,030
| +24% | +$33.9K |
|
2999
Zura Bio
ZURA
$511M
| $166K | ﹤0.01% |
25,090
+1,690
| +7% | +$11.3K |
|
3000
BRC Inc
BRCC
$116M
| $165K | ﹤0.01% |
46,050
+5,740
| +14% | +$25.3K |
|
Similar funds
AllianceBernstein's Q3 2023 Portfolio in Review
As of Q3 2023, AllianceBernstein held 3,241 positions worth $235B, down 4.1% from $245B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.2%. AllianceBernstein opened 78 new positions and exited 57, leaving the 3,241-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.
- AllianceBernstein's largest Q3 2023 buy was CRH: 5,431,009 shares worth $297M.
- AllianceBernstein added most to Netflix in Q3 2023, an estimated $595M increase.
- AllianceBernstein's biggest Q3 2023 reduction was Apple, cutting an estimated $384M.
- AllianceBernstein fully exited IVERIC bio, Inc. Common Stock in Q3 2023, selling an estimated $77.5M.
- AllianceBernstein's ten largest holdings make up 24% of its $235B portfolio in Q3 2023.
- AllianceBernstein opened 78 new positions and closed 57 in Q3 2023.
- AllianceBernstein's portfolio value fell 4.1% quarter-over-quarter to $235B.
Based on AllianceBernstein's 13F filing for Q3 2023, filed 14 Nov 2023.